Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Person › Details

Anja Pomrehn (MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR))

Pomrehn, Anja (MorphoSys 202010 SVP)

	Organisation	MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
	Group	Novartis (Group)
	Product	public relations / investor relations / marcom (services)
	Product 2	BIOTECH
	Source	MorphoSys AG. (10/13/20). "Press Release: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds [Not for US, AU, ZA, JP, et al.]". Planegg.

Record changed: 2024-07-17

Picture Berlin Partner Life Sciences Report 2024-2025 650x200px

More documents for Anja Pomrehn

[1] MorphoSys AG. (10/13/20). "Press Release: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds [Not for US, AU, ZA, JP, et al.]". Planegg....
[2] MorphoSys AG. (10/13/20). "Press Release: Ad hoc – MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds". Planegg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)